Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.

Functional & integrative genomics - 17 Mar 2023

Zhou Wenqian, Guo Jinping, Li Yujie, Ma Xiaoya, Yang Shuangyu, Wei Jie, Zhang Huan, Zhang Shanshan, Jin Tianbo

Abstract excerpt

Pharmacogenomics has been widely used to study the very important pharmacogenetic (VIP) variants among different populations. However, there is little pharmacogenomic information about the Chinese Hui population. Our research aimed to reveal the outstandingly different loci in the Hui population, and provide a theoretical foundation for personalized drug use in the Hui population, so as to facilitate more...

Topics

Join the communities discussing this publication.

Arylamine N-Acetyltransferase
China
Cyclooxygenase 2
Cytochrome P-450 CYP2D6
Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Pharmacogenetics

Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 36930384
DOI: 10.1007/s10142-023-01021-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.PMID 36930384Read ↗

Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.Semantic proximity Read ↗

The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.Semantic proximity Read ↗

Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.Semantic proximity Read ↗

Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.Semantic proximity Read ↗

Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.Semantic proximity Read ↗

Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China.Semantic proximity Read ↗

Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.